Ibandronate sodium
Ibandronate Sodium is a prescription injectable medication used to treat bone disorders like osteoporosis. It belongs to the bisphosphonate class and is administered intravenously. This generic version is manufactured by Accord Healthcare Inc. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Ibandronate Sodium is a prescription injectable medication used to treat bone disorders like osteoporosis. It belongs to the bisphosphonate class and is administered intravenously. This generic version is manufactured by Accord Healthcare Inc. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Ibandronate sodium",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Ibandronate sodium — ANDA 078948 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078948"
}
]
|
| identifier | ANDA078948 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"drug-manufacturers",
"health-care",
"pharmaceuticals"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Ibandronate sodium |
